Items where Author is "Bubendorf, L."

2016

Ruiz, C. and Kustermann, S. and Pietilae, E. and Vlajnic, T. and Baschiera, B. and Arabi, L. and Lorber, T. and Oeggerli, M. and Savic, S. and Obermann, E. and Singer, T. and Rothschild, S. I. and Zippelius, A. and Roth, A. B. and Bubendorf, L.. (2016) Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine. PLoS One, 11 (8). e0160807.

2013

Le Magnen, C. and Bubendorf, L. and Rentsch, C. A. and Mengus, C. and Gsponer, J. and Zellweger, T. and Rieken, M. and Thalmann, G. N. and Cecchini, M. G. and Germann, M. and Bachmann, A. and Wyler, S. and Heberer, M. and Spagnoli, G. C.. (2013) Characterization and clinical relevance of ALDHbright populations in prostate cancer. Clinical cancer research, Vol. 19, no. 19. pp. 5361-5371.

Le Magnen, C. and Bubendorf, L. and Ruiz, C. and Zlobec, I. and Bachmann, A. and Heberer, M. and Spagnoli, G. C. and Wyler, S. and Mengus, C.. (2013) Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells. European journal of cancer, Vol. 49, H. 4. pp. 955-963.

2012

Sais, G. and Wyler, S. and Hudolin, T. and Banzola, I. and Mengus, C. and Bubendorf, L. and Wild, P. J. and Hirsch, H. H. and Sulser, T. and Spagnoli, G. C. and Provenzano, M.. (2012) Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasia. Journal of virology, Vol. 86, H. 16. pp. 8461-8471.

Egli, A. and Bucher, C. and Dumoulin, A. and Stern, M. and Buser, A. and Bubendorf, L. and Gregor, M. and Servida, P. and Sommer, G. and Bremerich, J. and Gratwohl, A. and Khanna, N. and Widmer, A. F. and Battegay, M. and Tamm, M. and Hirsch, H. H. and Halter, J. P.. (2012) Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection, 40 (6). pp. 677-684.

Mamot, C. and Ritschard, R. and Wicki, A. and Stehle, G. and Dieterle, T. and Bubendorf, L. and Hilker, C. and Deuster, S. and Herrmann, R. and Rochlitz, C.. (2012) Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study. The Lancet oncology, Vol. 13, H. 12. pp. 1234-1241.

2011

Mengus, C. and Le Magnen, C. and Trella, E. and Yousef, K. and Bubendorf, L. and Provenzano, M. and Bachmann, A. and Heberer, M. and Spagnoli, G. C. and Wyler, S.. (2011) Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer. Journal of translational medicine, Vol. 9 , 162. p. 162.

Bubendorf, L.. (2011) [Preneoplastic lesions of pulmonary carcinoma]. Der Pathologe, Vol. 32, Suppl. 2. pp. 218-223.

2009

Tapia, C. and Savic, S. and Bihl, M. and Rufle, A. and Zlobec, I. and Terracciano, L. and Bubendorf, L.. (2009) EGFR-Mutationsanalyse beim nichtkleinzelligen Lungenkarzinom. Der Pathologe : Pathologie und Klinik : Organ von: Internationale Akademie für Pathologie Deutsche Abteilung e.V. ... [et al.], Vol. 30. pp. 384-392.

2008

Savic, S. and Tapia, C. and Grilli, B. and Rufle, A. and Bihl, M. P. and de Vito Barascud, A. and Herzog, M. and Terracciano, L. and Baty, F. and Bubendorf, L.. (2008) Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers. British journal of cancer, Vol. 98, no. 1. pp. 154-160.

Feder-Mengus, C. and Wyler, S. and Hudolin, T. and Ruszat, R. and Bubendorf, L. and Chiarugi, A. and Pittelli, M. and Weber, W. P. and Bachmann, A. and Gasser, T. C. and Sulser, T. and Heberer, M. and Spagnoli, G. C. and Provenzano, M.. (2008) High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. European journal of cancer, Vol. 44. pp. 2266-2675.

Kaulfuss, S. and Grzmil, M. and Hemmerlein, B. and Thelen, P. and Schweyer, S. and Neesen, J. and Bubendorf, L. and Glass, A. G. and Jarry, H. and Auber, B. and Burfeind, P.. (2008) Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells. Molecular endocrinology, Vol. 22. pp. 1606-1621.

D'Addario, G. and Rauch, D. and Stupp, R. and Pless, M. and Stahel, R. and Mach, N. and Jost, L. and Widmer, L. and Tapia, C. and Bihl, M. and Mayer, M. and Ribi, K. and Lerch, S. and Bubendorf, L. and Betticher, D. C.. (2008) Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC) : SAKK protocol 19/03. Annals of oncology, Vol. 19. pp. 739-745.

Abdulghani, J. and Gu, L. and Dagvadorj, A. and Lutz, J. and Leiby, B. and Bonuccelli, G. and Lisanti, M. P. and Zellweger, T. and Alanen, K. and Mirtti, T. and Visakorpi, T. and Bubendorf, L. and Nevalainen, M. T.. (2008) Stat3 promotes metastatic progression of prostate cancer. American Journal of Pathology, Vol. 172, no. 6. pp. 1717-1728.

Tan, S. H. and Dagvadorj, A. and Shen, F. and Gu, L. and Liao, Z. and Abdulghani, J. and Zhang, Y. and Gelmann, E. P. and Zellweger, T. and Culig, Z. and Visakorpi, T. and Bubendorf, L. and Kirken, R. A. and Karras, J. and Nevalainen, M. T.. (2008) Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells. Cancer research, 68,1. pp. 236-248.

2006

Walter, M. A. and Seboek, D. and Demougin, P. and Bubendorf, L. and Oberholzer, M. and Muller-Brand, J. and Muller, B.. (2006) Extraction of high-integrity RNA suitable for microarray gene expression analysis from long-term stored human thyroid tissues. Pathology, 38 (3). pp. 249-253.